AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 1 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,299 | -88.8% | 3,025 | -80.6% | 0.00% | -83.3% |
Q2 2023 | $172,672 | +169186.3% | 15,570 | +134.5% | 0.01% | +100.0% |
Q1 2023 | $102 | -74.5% | 6,640 | -63.1% | 0.00% | -82.4% |
Q4 2022 | $400 | -99.8% | 18,002 | +75.0% | 0.02% | +466.7% |
Q3 2022 | $168,000 | +5.0% | 10,286 | -6.6% | 0.00% | -25.0% |
Q2 2022 | $160,000 | +515.4% | 11,013 | +690.6% | 0.00% | – |
Q1 2022 | $26,000 | -75.5% | 1,393 | -68.8% | 0.00% | -100.0% |
Q4 2021 | $106,000 | +341.7% | 4,460 | +364.6% | 0.00% | +100.0% |
Q3 2021 | $24,000 | -85.0% | 960 | -85.2% | 0.00% | -75.0% |
Q2 2021 | $160,000 | +416.1% | 6,474 | +356.6% | 0.00% | +300.0% |
Q1 2021 | $31,000 | +6.9% | 1,418 | +26.8% | 0.00% | 0.0% |
Q4 2020 | $29,000 | -60.8% | 1,118 | -57.5% | 0.00% | 0.0% |
Q3 2020 | $74,000 | – | 2,628 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |